Phibro Animal Health Corporation (PAHC)
$38.30+2.41%Close
BUYRECOVERY · day 6
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.6B
- Beta
- 0.42
- Div yield
- 1.31%
- P/E (TTM)
- 14.88
- Short % float
- 2.54%
- Days to cover
- 4.1
- SI change
- -10.6%
- 1W
- +2.85%
- 1M
- +4.70%
- vs SPY 1W
- +1.69%
- vs SPY 1M
- +1.71%
Industry peers
FMP comparable companies · ranked by market cap
- OGNBUYOrganon & Co.$3.6BBULLQ -2$13.70+0.44%
- MDSELLPediatrix Medical Group, Inc.$2.1BBULLQ 15$26.10+1.52%
- AVDLAvadel Pharmaceuticals plc$2.1B$21.64
- ALVOBUYAlvotech$2.1BRECOVERYQ -3$6.11+1.94%
- AUPHSELLAurinia Pharmaceuticals Inc.$2.0BBEARQ 22$15.72+2.65%
- ANIPSELLANI Pharmaceuticals, Inc.$1.7BRECOVERYQ 9$72.58+2.65%
- MNKDSELLMannKind Corporation$1.2BCRISISQ 4$3.82-3.80%
- EVOSELLEvotec SE$590MCRISISQ 16$1.66-2.55%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PAHC?
- LOPJLB’s latest quantitative signal on Phibro Animal Health Corporation (PAHC) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is PAHC in?
- Phibro Animal Health Corporation (PAHC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Phibro Animal Health Corporation (PAHC) do?
- Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Pr…